The Tisch Cancer Institute and the Precision Immunology Institute at the Icahn School of Medicine at Mount Sinai have launched the Center for Computational Immunology, a hub that will help researchers studying cancer, genomics, machine learning, and immunology collaborate to find targeted immunotherapies.
More than a year after a catastrophic shortage of platinum-based chemotherapy drugs swept through the U.S., FDA on June 28 officially removed carboplatin and cisplatin from the drug shortage list.
